These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38360688)

  • 1. New score to predict COVID-19 progression in vaccine and early treatment era: the COVID-19 Sardinian Progression Score (CSPS).
    De Vito A; Saderi L; Colpani A; Puci MV; Zauli B; Fiore V; Fois M; Meloni MC; Bitti A; Moi G; Maida I; Babudieri S; Sotgiu G; Madeddu G
    Eur J Med Res; 2024 Feb; 29(1):123. PubMed ID: 38360688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression.
    De Vito A; Colpani A; Saderi L; Puci M; Zauli B; Fiore V; Fois M; Meloni MC; Bitti A; Di Castri C; Maida I; Babudieri S; Sotgiu G; Madeddu G
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals.
    Vo AD; La J; Wu JT; Strymish JM; Ronan M; Brophy M; Do NV; Branch-Elliman W; Fillmore NR; Monach PA
    JAMA Netw Open; 2022 Oct; 5(10):e2240037. PubMed ID: 36264571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spatial and temporal distribution and predictive value of chest CT scoring in patients with COVID-19].
    Li S; Liu SY; Zhao YQ; Li QY; Liu DY; Liu ZC; Li DS; Zeng L; Ge QG; Ma QB; Shen N
    Zhonghua Jie He He Hu Xi Za Zhi; 2021 Mar; 44(3):230-236. PubMed ID: 33721937
    [No Abstract]   [Full Text] [Related]  

  • 6. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis.
    Smith JB; Gonzales EG; Li BH; Langer-Gould A
    JAMA Netw Open; 2022 Dec; 5(12):e2248664. PubMed ID: 36576740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study.
    De Vito A; Colpani A; Poliseno M; Diella L; Ieva FRP; Belati A; Papale R; Babudieri S; De Santis L; Saracino A; Lo Caputo S; Madeddu G
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of quantitative analysis in lung computed tomography in patients severely ill with COVID-19.
    Rorat M; Jurek T; Simon K; Guziński M
    PLoS One; 2021; 16(5):e0251946. PubMed ID: 34015025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the clinical characteristics and early warning model construction of severe/critical coronavirus disease 2019 patients].
    Xu J; Zhao F; Han M; Ma L; Zhang T
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):401-406. PubMed ID: 32527341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
    Aricò E; Castiello L; Bracci L; Urbani F; Lombardo F; Bacigalupo I; Ancidoni A; Vanacore N; Falcione A; Reggiani C; Dutti GM; Maglie MG; Papa O; Bartoletti PL; Ozzella G; Bevilacqua N; Nicastri E; Belardelli F; Sconocchia G
    Trials; 2021 Sep; 22(1):584. PubMed ID: 34479601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.
    Poletti P; Tirani M; Cereda D; Trentini F; Guzzetta G; Sabatino G; Marziano V; Castrofino A; Grosso F; Del Castillo G; Piccarreta R; Andreassi A; Melegaro A; Gramegna M; Ajelli M; Merler S;
    JAMA Netw Open; 2021 Mar; 4(3):e211085. PubMed ID: 33688964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].
    Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of charlson comorbidity index on mortality from SARS-CoV-2 virus infection and A novel COVID-19 mortality index: CoLACD.
    Varol Y; Hakoglu B; Kadri Cirak A; Polat G; Komurcuoglu B; Akkol B; Atasoy C; Bayramic E; Balci G; Ataman S; Ermin S; Yalniz E;
    Int J Clin Pract; 2021 Apr; 75(4):e13858. PubMed ID: 33237615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.
    Grasselli G; Zanella A; Carlesso E; Florio G; Canakoglu A; Bellani G; Bottino N; Cabrini L; Castelli GP; Catena E; Cecconi M; Cereda D; Chiumello D; Forastieri A; Foti G; Gemma M; Giudici R; Grazioli L; Lombardo A; Lorini FL; Madotto F; Mantovani A; Mistraletti G; Mojoli F; Mongodi S; Monti G; Muttini S; Piva S; Protti A; Rasulo F; Scandroglio AM; Severgnini P; Storti E; Fumagalli R; Pesenti A;
    JAMA Netw Open; 2022 Oct; 5(10):e2238871. PubMed ID: 36301541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of the SOFA score in patients with COVID-19: A retrospective, observational study.
    Yang Z; Hu Q; Huang F; Xiong S; Sun Y
    Medicine (Baltimore); 2021 Aug; 100(32):e26900. PubMed ID: 34397917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined prognostic value of serum lactic acid, procalcitonin and severity score for short-term prognosis of septic shock patients].
    Hao C; Hu Q; Zhu L; Xu H; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):281-285. PubMed ID: 33834968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.